Ossianix Announces Publication of Positive Preclinical Data on Neutralizing SARS-CoV-2 Infection with a Panel of Single Domain Shark VNAR Antibodies
Published on 10 Jun 2021
Exploristics signs collaboration agreement with Istesso to embed study simulation into clinical development with innovative software platform KerusCloud
Published on 4 Jun 2021
New data presented at Virtual EULAR 2021 Congress by AKL Research and Development demonstrate its investigational osteoarthritis drug APPA reduces senescence and reactive oxygen species production
Published on 2 Jun 2021
Cytiva acquires GoSilico to strengthen digital capabilities in bioprocessing
Published on 2 Jun 2021
Plasticell announces completion of £1.4 million equity financing round
Published on 28 May 2021
FourPlus and Cell and Gene Therapy Catapult deliver cutting-edge VR training technology
Published on 27 May 2021
PostEra and LifeArc collaborate on novel open science initiative to develop new antiviral for COVID-19
Published on 20 May 2021
Cytiva supports Prestige Biopharma to develop antibody therapies and manufacture COVID-19 vaccines
Published on 17 May 2021
Achilles Therapeutics Receives Horizon 2020 Grant as Part of Neoantigen Consortium
Published on 6 May 2021

Peptinnovate announces change of name to Immune Regulation, strengthening of the Board and successful fundraise

Read the article
The appointment of these three experienced industry executives will bring valuable insight and resource to our Board and executive team. With their skills in immunology, clinical therapeutic development and strategy we have the expertise to advance our clinical programmes and look forward to the next stage of our progress.
Prof. Clive Page
Chairman of Immune Regulation
Exploristics - Launch of KerusCloud Spring 2021 release
Published on 5 May 2021
LifeArc invests in Cumulus Neuroscience
Published on 4 May 2021
New data presented at OARSI 2021 Virtual World Congress by AKL Research and Development advances understanding of biological effects of its investigational osteoarthritis drug APPA to protect against joint damage
Published on 29 Apr 2021
Cytiva strengthens commitment to foster talent pool in Korea
Published on 28 Apr 2021
Cell and Gene Therapy Catapult news: ATTC network establishes first Advanced Therapies NHS Readiness Toolkit
Published on 26 Apr 2021
AKL Research and Development news: APPA Phase II human study completes patient recruitment a month ahead of schedule
Published on 26 Apr 2021
Industry leaders launch HealthHub 21 to scale-up digital solutions for faster & more accessible care
Published on 21 Apr 2021
Myricx Pharma Announces Board and Executive Appointments
Published on 20 Apr 2021
Autolus Therapeutics Receives Innovation Passport and entry into ILAP for AUTO4 for the treatment of T cell receptor constant region beta chain 1 (TRBC1) positive T cell lymphomas
Published on 20 Apr 2021
Revolo Biotherapeutics Enters Manufacturing Agreement with CordenPharma to Scale Up and Manufacture ‘1104 for the Treatment of Eosinophilic Esophagitis and Allergic Disease
Published on 15 Apr 2021
Lonza Celebrates 20 th Anniversary of Nucleofector™ Cell Transfection Platform
Published on 7 Apr 2021
Autolus Therapeutics Announces Updated Manufacturing Facility Strategy Leveraging its UK Operations
Published on 29 Mar 2021

Copyright © 2021 Stevenage Bioscience Catalyst

Designed and built by Onespacemedia

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.